These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15208686)

  • 1. Functional role of MIA in melanocytes and early development of melanoma.
    Poser I; Tatzel J; Kuphal S; Bosserhoff AK
    Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
    Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
    Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
    Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Hugl-1 is strongly reduced in malignant melanoma.
    Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
    Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
    Tatzel J; Poser I; Schroeder J; Bosserhoff AK
    Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
    Rothhammer T; Bosserhoff AK
    Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA.
    Tscheudschilsuren G; Bosserhoff AK; Schlegel J; Vollmer D; Anton A; Alt V; Schnettler R; Brandt J; Proetzel G
    Exp Cell Res; 2006 Jan; 312(1):63-72. PubMed ID: 16256983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
    Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.
    Sadej R; Spychala J; Skladanowski AC
    Melanoma Res; 2006 Jun; 16(3):213-22. PubMed ID: 16718268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
    Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
    J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
    Kuphal S; Bosserhoff AK
    Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma.
    Marr DG; Poser I; Shellman YG; Bosserhoff AK; Norris DA
    Int J Oncol; 2004 Jul; 25(1):105-11. PubMed ID: 15201995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
    Guba M; Bosserhoff AK; Steinbauer M; Abels C; Anthuber M; Buettner R; Jauch KW
    Br J Cancer; 2000 Nov; 83(9):1216-22. PubMed ID: 11027436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of MIA protein by mutagenesis.
    Stoll R; Lodermeyer S; Bosserhoff AK
    Biol Chem; 2006 Dec; 387(12):1601-6. PubMed ID: 17132106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional implication of truncated P-cadherin expression in malignant melanoma.
    Bauer R; Bosserhoff AK
    Exp Mol Pathol; 2006 Dec; 81(3):224-30. PubMed ID: 16919267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Dickkopf genes is strongly reduced in malignant melanoma.
    Kuphal S; Lodermeyer S; Bataille F; Schuierer M; Hoang BH; Bosserhoff AK
    Oncogene; 2006 Aug; 25(36):5027-36. PubMed ID: 16568085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens.
    Perez RP; Zhang P; Bosserhoff AK; Buettner R; Abu-Hadid M
    Hum Pathol; 2000 Nov; 31(11):1381-8. PubMed ID: 11112213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
    J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.